The dilemma, causes and approaches to avoid recurrent hospital readmissions for patients with chronic heart failure
暂无分享,去创建一个
[1] C. Yancy,et al. Get with the guidelines steering committee and hospitals, sex and racial differences in the use of implantable cardioverter & defibrillators among patients hospitalized with heart failure , 2007 .
[2] W. Maisel,et al. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. , 2003, The American journal of cardiology.
[3] M. Cheitlin. Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events , 2010 .
[4] K. Ellison,et al. Predictors of hospital readmission after discharge in patients with congestive heart failure. , 2005, Heart & lung : the journal of critical care.
[5] C. O'connor,et al. Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF , 2008, Circulation. Heart failure.
[6] Y Wang,et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.
[7] Harlan M Krumholz,et al. Representation of the elderly, women, and minorities in heart failure clinical trials. , 2002, Archives of internal medicine.
[8] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[9] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.
[10] M. Bristow,et al. Economic impact of heart failure in the United States: time for a different approach. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[11] C. O'connor,et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. , 2008, Archives of internal medicine.
[12] A. Takeshita,et al. Medical and socioenvironmental predictors of hospital readmission in patients with congestive heart failure. , 2001, American heart journal.
[13] T. Kasai,et al. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. , 2008, Chest.
[14] S. Yusuf,et al. Acute precipitants of congestive heart failure exacerbations. , 2001, Archives of internal medicine.
[15] John L Sapp,et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.
[16] R. Eaton,et al. Myxedema-associated Cardiogenic Shock Treated with Intravenous Triiodothyronine , 1992, Annals of Internal Medicine.
[17] K M Hla,et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. , 1997, Archives of internal medicine.
[18] Sana M. Al-Khatib,et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. , 2010, Journal of the American College of Cardiology.
[19] C M O'Connor,et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. , 2001, Archives of internal medicine.
[20] B. Jonathan. Comprehensive discharge planning and home follow-up of hospitalized elders: A randomized clinical trial , 1999 .
[21] Anne L. Taylor,et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. , 2004, New England Journal of Medicine.
[22] A. di Lenarda,et al. [Prevention of heart failure]. , 2010, Giornale italiano di cardiologia.
[23] G. Murray,et al. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .
[24] M. Pfeffer,et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial , 2005, The Lancet.
[25] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[26] John E A Blair,et al. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure. , 2008, JACC. Cardiovascular imaging.
[27] A. Moss,et al. Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II , 2006, Circulation.
[28] S. Stewart,et al. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. , 1998, Archives of internal medicine.
[29] M. Zile,et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. , 2008, Journal of the American College of Cardiology.
[30] Jerome J. Schentag,et al. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure. , 1998, The American journal of cardiology.
[31] C. Yancy,et al. Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF). , 2009, American heart journal.
[32] J. Rouleau,et al. Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial , 2005, Canadian Medical Association Journal.
[33] G. Fonarow,et al. Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. , 2009, Journal of the American College of Cardiology.
[34] S. Manzano-Fernández,et al. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. , 2009, The American journal of cardiology.
[35] J. McMurray,et al. Randomised controlled trial of specialist nurse intervention in heart failure , 2001, BMJ : British Medical Journal.
[36] Y Wang,et al. Predictors of readmission among elderly survivors of admission with heart failure. , 2000, American heart journal.
[37] William T. Abraham,et al. Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients: Initial Experience With a New Permanent Implantable Device , 2007, Circulation.
[38] D. DeMets,et al. Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.
[39] A. Takeshita,et al. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. , 2001, The American journal of cardiology.
[40] F. Sheehan,et al. Myocyte degeneration and cell death in hibernating human myocardium. , 1996, Journal of the American College of Cardiology.
[41] Therapy Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure , 1993, The Lancet.
[42] William T. Abraham,et al. Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure , 2010, Circulation.
[43] C. O’loughlin,et al. Causes and consequences of nonpersistence with heart failure medication. , 2009, The American journal of cardiology.
[44] A. Gackowski,et al. Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure , 2005 .
[45] E. Rackow. Rehospitalizations among patients in the Medicare fee-for-service program. , 2009, The New England journal of medicine.
[46] A. Norberg,et al. An Intervention Aimed at Reducing Uncertainty in Elderly Patients with Chronic Heart Failure , 2000, International Journal for Human Caring.
[47] Christianna S. Williams,et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. , 1998, Circulation.
[48] P. Nicod,et al. The Thyroid and the Heart , 1993, Circulation.
[49] J. Cahill,et al. Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high‐risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin‐converting enzyme inhibitor dose at discharge , 2001, European journal of heart failure.
[50] Gesica Investigators. Randomised trial of telephone intervention in chronic heart failure: DIAL trial , 2005, BMJ : British Medical Journal.
[51] H. Yagi,et al. Decreased renal function as an independent predictor of re-hospitalization for congestive heart failure. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[52] P A Poole-Wilson,et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. , 1999, Circulation.
[53] D. DeMets,et al. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.
[54] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[55] David D. Shin,et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. , 2007, Archives of internal medicine.
[56] R. Califf,et al. Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) , 2008, Circulation. Heart failure.
[57] K. Witte,et al. Chronic heart failure and multiple micronutrient supplementation: realistic hope or idealistic conjecture? , 2005, Heart failure monitor.
[58] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[59] Gabriel Thabut,et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. , 2004, Journal of the American College of Cardiology.
[60] K. Grumbach,et al. Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity. , 1999, American heart journal.
[61] B. Pitt,et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .
[62] E. Aliot,et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.
[63] Ibrahim N. Mansour,et al. Six minute walk test predicts long-term all-cause mortality and heart failure rehospitalization in African-American patients hospitalized with acute decompensated heart failure. , 2009, Journal of cardiac failure.
[64] L. Lenert,et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. , 2001, Journal of the American College of Cardiology.
[65] Harlan M Krumholz,et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. , 2002, Journal of the American College of Cardiology.
[66] L. Erhardt,et al. Cost effective management programme for heart failure reduces hospitalisation , 1998, Heart.
[67] M. Quiñones,et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. , 2005, Journal of the American College of Cardiology.
[68] C. O'connor,et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. , 2003, The American journal of cardiology.
[69] Harlan M. Krumholz,et al. Recent National Trends in Readmission Rates After Heart Failure Hospitalization , 2010, Circulation. Heart failure.
[70] M. Bristow,et al. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. , 1996, Circulation.
[71] I. Alhaddad,et al. A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients. , 2001, Journal of the American College of Cardiology.
[72] R. Carney,et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. , 1995, The New England journal of medicine.
[73] John G F Cleland,et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. , 2007, Journal of cardiac failure.
[74] R. Cooper,et al. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. , 1988, Archives of internal medicine.
[75] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.
[76] Effect of carvedilol on survival in severe chronic heart failure. , 2001 .
[77] J. Conti,et al. Current trends in heart failure readmission rates: analysis of medicare data , 2009, Clinical cardiology.
[78] Sharon-Lise T. Normand,et al. An Administrative Claims Measure Suitable for Profiling Hospital Performance on the Basis of 30-Day All-Cause Readmission Rates Among Patients With Heart Failure , 2008, Circulation. Cardiovascular quality and outcomes.
[79] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[80] J. McMurray,et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. , 2004, Journal of the American College of Cardiology.
[81] N. Sharpe,et al. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.
[82] Haya R Rubin,et al. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. , 2004, JAMA.
[83] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[84] E. J. Brown,et al. The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.
[85] Gerasimos Filippatos,et al. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. , 2007, Journal of cardiac failure.
[86] I. Kubota,et al. Combination of conventional biomarkers for risk stratification in chronic heart failure. , 2009, Journal of cardiology.
[87] S. Yusuf,et al. Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .
[88] G. Fonarow,et al. Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. , 2009, The American journal of medicine.
[89] Simon Stewart,et al. Home-Based Intervention in Congestive Heart Failure: Long-Term Implications on Readmission and Survival , 2002, Circulation.
[90] H. Yagi,et al. Inhibition of the renin-angiotensin system prevents re-hospitalization of heart failure patients with preserved ejection fraction. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[91] L. Carbone,et al. Macro- and micronutrients in African-Americans with heart failure , 2006, Heart Failure Reviews.
[92] D. Mozaffarian,et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.
[93] D. Battleman,et al. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. , 2002, Archives of internal medicine.
[94] Paula Finn,et al. American Heart Association--scientific sessions 2005. 13-16 November 2005, Dallas, TX, USA. , 2006, IDrugs : the investigational drugs journal.
[95] L. Stevenson,et al. CardioMEMS Heart Sensor Allows Monitoring of Pressures to Improve Outcomes in NYHA Class III Heart Failure Patients (CHAMPION) Trial: Impact of Hemodynamic Guided Care on Patients With Preserved Ejection Fraction , 2010 .
[96] B. Kozłowski. [Commentary to the article: Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-38]. , 2009, Kardiologia polska.
[97] G. Schulz,et al. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. , 1998, Journal of the American College of Cardiology.
[98] A. Casta,et al. Cardiac complications in juvenile hyperthyroidism. , 1984, American journal of diseases of children.
[99] W. Kannel,et al. Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.
[100] P. Armstrong,et al. Renal Insufficiency and Heart Failure: Prognostic and Therapeutic Implications From a Prospective Cohort Study , 2004, Circulation.
[101] Harlan M Krumholz,et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. , 2006, Journal of the American College of Cardiology.
[102] L Goldman,et al. Correlates of early hospital readmission or death in patients with congestive heart failure. , 1997, The American journal of cardiology.
[103] W. Tang,et al. Aldosterone-Receptor Antagonists in Heart Failure: Insights After EMPHASIS-HF , 2011, Current heart failure reports.
[104] J. Keaney,et al. Are ACE inhibitors a "magic bullet" against oxidative stress? , 2001, Circulation.
[105] R. Cody,et al. Discharge Education Improves Clinical Outcomes in Patients With Chronic Heart Failure , 2005, Circulation.
[106] J. Killian,et al. Prognostic Value of Biomarkers in Heart Failure: Application of Novel Methods in the Community , 2009, Circulation. Heart failure.